The United States should not greenlight Chinese drugs while drowning American companies in red tape, Sen. Tom Cotton (R-AR) said during an event with Breitbart News, highlighting the threats of China.
Part of the discussion centered around the shocking reality that the U.S. is allowing Chinese companies to make knockoffs or compounds of American drugs with what host Matthew Boyle described as “cheap, weird ingredients that they’re unclear about.”
Read the full article at BREITBART.COM
